185 related articles for article (PubMed ID: 27849428)
1. Germline Polymorphisms of the VEGF Pathway Predict Recurrence in Nonadvanced Differentiated Thyroid Cancer.
Marotta V; Sciammarella C; Capasso M; Testori A; Pivonello C; Chiofalo MG; Gambardella C; Grasso M; Antonino A; Annunziata A; Macchia PE; Pivonello R; Santini L; Botti G; Losito S; Pezzullo L; Colao A; Faggiano A
J Clin Endocrinol Metab; 2017 Feb; 102(2):661-671. PubMed ID: 27849428
[TBL] [Abstract][Full Text] [Related]
2. Influence of vascular endothelial growth factor single nucleotide polymorphisms on non-small cell lung cancer tumor angiogenesis.
Maeda A; Nakata M; Yasuda K; Yukawa T; Saisho S; Okita R; Hirami Y; Shimizu K
Oncol Rep; 2013 Jan; 29(1):39-44. PubMed ID: 23064377
[TBL] [Abstract][Full Text] [Related]
3. Combined effect of vascular endothelial growth factor and its receptor polymorphisms in endometriosis: a case-control study.
Cardoso JV; Abrão MS; Vianna-Jorge R; Ferrari R; Berardo PT; Machado DE; Perini JA
Eur J Obstet Gynecol Reprod Biol; 2017 Feb; 209():25-33. PubMed ID: 27836223
[TBL] [Abstract][Full Text] [Related]
4. VEGF polymorphisms in early cervical cancer susceptibility, angiogenesis, and survival.
Kim YH; Kim MA; Park IA; Park WY; Kim JW; Kim SC; Park NH; Song YS; Kang SB
Gynecol Oncol; 2010 Nov; 119(2):232-6. PubMed ID: 20797778
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor polymorphisms and esophageal cancer prognosis.
Bradbury PA; Zhai R; Ma C; Xu W; Hopkins J; Kulke MJ; Asomaning K; Wang Z; Su L; Heist RS; Lynch TJ; Wain JC; Christiani D; Liu G
Clin Cancer Res; 2009 Jul; 15(14):4680-5. PubMed ID: 19584152
[TBL] [Abstract][Full Text] [Related]
6. Investigation of VEGF and IL-8 Gene Polymorphisms in Patients with Differentiated Thyroid Cancer.
Kilic I; Guldiken S; Sipahi T; Palabiyik O; Akker M; Celik O; Soysal-Atile N; Tuncbilek N; Guven HM; Gundogdu AS; Sut N
Clin Lab; 2016 Dec; 62(12):2319-2325. PubMed ID: 28164553
[TBL] [Abstract][Full Text] [Related]
7. Microvessel density and the association with single nucleotide polymorphisms of the vascular endothelial growth factor receptor 2 in patients with colorectal cancer.
Hansen TF; Sørensen FB; Spindler KL; Olsen DA; Andersen RF; Lindebjerg J; Brandslund I; Jakobsen A
Virchows Arch; 2010 Mar; 456(3):251-60. PubMed ID: 20143086
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 gene polymorphisms in patients with gastrointestinal stromal tumors.
Kang BW; Kim JG; Chae YS; Bae HI; Kwon O; Chung HY; Yu W; Song HS; Kang YN; Ryu SW; Lee KH; Bae YK; Choi JH; Kim SW; Ryoo HM; Cho CH; Chae HD; Park KW; Gu MJ; Bae BJ
Asia Pac J Clin Oncol; 2014 Jun; 10(2):e40-5. PubMed ID: 23551429
[TBL] [Abstract][Full Text] [Related]
9. Associations between single-nucleotide polymorphisms of the VEGF gene and long-term prognosis of oral squamous cell carcinoma.
Kämmerer PW; Koch FP; Schiegnitz E; Kumar VV; Berres M; Toyoshima T; Al-Nawas B; Brieger J
J Oral Pathol Med; 2013 May; 42(5):374-81. PubMed ID: 23227881
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of vascular endothelial growth factor gene polymorphisms in patients with colorectal cancer.
Jang MJ; Kim JW; Jeon YJ; Chong SY; Oh D; Kim NK
Int J Clin Oncol; 2013 Dec; 18(6):1032-41. PubMed ID: 23132736
[TBL] [Abstract][Full Text] [Related]
11. VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: the ALICE-1 study.
Scartozzi M; Faloppi L; Svegliati Baroni G; Loretelli C; Piscaglia F; Iavarone M; Toniutto P; Fava G; De Minicis S; Mandolesi A; Bianconi M; Giampieri R; Granito A; Facchetti F; Bitetto D; Marinelli S; Venerandi L; Vavassori S; Gemini S; D'Errico A; Colombo M; Bolondi L; Bearzi I; Benedetti A; Cascinu S
Int J Cancer; 2014 Sep; 135(5):1247-56. PubMed ID: 24510746
[TBL] [Abstract][Full Text] [Related]
12. Recurrences in stage II rectal carcinoma after curative resection alone: from the viewpoint of angiogenesis.
Martinović Ž; Kovač D; Martinović C
World J Surg Oncol; 2016 Apr; 14():122. PubMed ID: 27102733
[TBL] [Abstract][Full Text] [Related]
13. Impact of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) single nucleotide polymorphisms on outcome in gastroenteropancreatic neuroendocrine neoplasms.
Berardi R; Torniai M; Partelli S; Rubini C; Pagliaretta S; Savini A; Polenta V; Santoni M; Giampieri R; Onorati S; Barucca F; Murrone A; Bianchi F; Falconi M
PLoS One; 2018; 13(5):e0197035. PubMed ID: 29787601
[TBL] [Abstract][Full Text] [Related]
14. Relationship between VEGFA polymorphisms and serum VEGF protein levels and recurrent spontaneous miscarriage.
Almawi WY; Saldanha FL; Mahmood NA; Al-Zaman I; Sater MS; Mustafa FE
Hum Reprod; 2013 Oct; 28(10):2628-35. PubMed ID: 23900206
[TBL] [Abstract][Full Text] [Related]
15. Endocan-expressing microvessel density as a prognostic factor for survival in human gastric cancer.
Chang Y; Niu W; Lian PL; Wang XQ; Meng ZX; Liu Y; Zhao R
World J Gastroenterol; 2016 Jun; 22(23):5422-9. PubMed ID: 27340359
[TBL] [Abstract][Full Text] [Related]
16. Effect of vascular endothelial growth factor polymorphisms on survival in advanced-stage non-small-cell lung cancer.
Masago K; Fujita S; Kim YH; Hatachi Y; Fukuhara A; Nagai H; Irisa K; Ichikawa M; Mio T; Mishima M
Cancer Sci; 2009 Oct; 100(10):1917-22. PubMed ID: 19594543
[TBL] [Abstract][Full Text] [Related]
17. Characterisation of tumour microvessel density during progression of high-grade serous ovarian cancer: clinico-pathological impact (an OCTIPS Consortium study).
Ruscito I; Cacsire Castillo-Tong D; Vergote I; Ignat I; Stanske M; Vanderstichele A; Glajzer J; Kulbe H; Trillsch F; Mustea A; Kreuzinger C; Benedetti Panici P; Gourley C; Gabra H; Nuti M; Taube ET; Kessler M; Sehouli J; Darb-Esfahani S; Braicu EI
Br J Cancer; 2018 Aug; 119(3):330-338. PubMed ID: 29955134
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor receptor 2 gene polymorphisms as predictors for tumor recurrence and overall survival in non-small-cell lung cancer.
Uzunoglu FG; Kaufmann C; Wikman H; Güngör C; Bohn BA; Nentwich MF; Reeh M; Pantel K; Bockhorn M; Kutup A; Mann O; Izbicki JR; Vashist YK
Ann Surg Oncol; 2012 Jul; 19(7):2159-68. PubMed ID: 22395975
[TBL] [Abstract][Full Text] [Related]
19. VEGFR-2, CXCR-2 and PAR-1 germline polymorphisms as predictors of survival in pancreatic carcinoma.
Uzunoglu FG; Kolbe J; Wikman H; Güngör C; Bohn BA; Nentwich MF; Reeh M; König AM; Bockhorn M; Kutup A; Mann O; Izbicki JR; Vashist YK
Ann Oncol; 2013 May; 24(5):1282-90. PubMed ID: 23293110
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor pathway polymorphisms as prognostic and pharmacogenetic factors in cancer: a systematic review and meta-analysis.
Eng L; Azad AK; Habbous S; Pang V; Xu W; Maitland-van der Zee AH; Savas S; Mackay HJ; Amir E; Liu G
Clin Cancer Res; 2012 Sep; 18(17):4526-37. PubMed ID: 22733538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
